Clinical study on Tonghua Liyan Decoction in the treatment of gastroesophageal reflux associated pharyngitis

Phase 1

Recruiting

• Conditions: Gastroesophageal reflux disease

• Registration Number: ITMCTR2000003752
• Lead Sponsor: Yueyang Integrated Traditional Chinese and Western Medicine Hospital affiliated to Shanghai University of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Patients who meet the diagnostic criteria of gastroesophageal reflux disease;
2. Patients who failed to take standard dose PPI for four weeks or more before this study;
3. Patients aged 18-70 years, regardless of gender.

Exclusion Criteria

1. Patients with one of the following diseases: peptic ulcer, history of gastroesophageal and duodenal surgery, Zhuo AI syndrome, primary esophageal motility disorders (such as achalasia, scleroderma, primary esophageal spasm), malignant lesions of upper gastrointestinal tract, coronary heart disease, diabetes, drug-induced esophagitis, and psychotic patients.
2. Pregnant women and patients with allergic constitution.
3. The patient himself is the researcher directly involved in the clinical study.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cure rate;Adverse events;

Secondary Outcome Measures

Name	Time	Method
Recurrence rate;Remission rate;Quality of life;